Estimation of out of pocket expenditure on COVID-19 management among patients treated at home, Iraq, 2020
ABSTRACT
Background:
There is a global consensus that the socio-economic impact of the COVID-19 crisis is a devastating effect on health programs and health insurance. with losses of jobs and rising prices causing growing poverty.
Objective:
Estimate the out-of-pocket expenditure spent on management of COVID-19 patients exclusively treated at home.
Methods:
Cross-sectional study was conducted, and data were collected from participated COVID-19 patients in Iraq through snowball sampling by using a questionnaire, Enrollment occurred from November. 1st to December 31, 2020 and excluded individuals who were entering the hospitals.
Results:
Among 589 participated COVID-19 patients, 328 females (55.7%). Females spent more than males to get cured of the illness, the mean amount of money spent by women is statistically higher than male (644.617 ID), (402S). 461.653 ID (307S) respectively, the average total money expenditures spent was 643,304 ID (428S), range (505 ,096-5,595,000 ID),which is around (336S - 3730S) among patients exclusively treated at home. The average of money spent by patients with inadequate monthly income (901,424 ID), (600S) range (220,000-5260000 ID) ( 140S- 3500S) was significantly more than patients with adequate monthly income 613,252 ID around( 400S) range (48.000-5,500.000 ID) (32$ - 3600$). COVID-19 patients (25.5%) who had chronic diseases spent significantly more money (696,330ID),(460$) than those without the chronie disease (625,185 ID).(416$).
Conclusions:
Financial burdens affected the purchasing power, the economic situation on the management of COVID-19 patients exclusively treated at home.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.